TB treatment: latest news

TB treatment resources

TB treatment features

TB treatment in your own words

TB treatment news from aidsmap

More news

TB treatment news selected from other sources

  • Ukraine’s TB problem is ticking time bomb for Europe

    Controlling the airborne disease takes on additional urgency this year as the country seeks to integrate into EU with a new visa-free regime.

    29 August 2017 | Politico
  • The 2017 Pipeline Report

    Treatment Action Group (TAG) announces the launch of its annual research and development landscape analysis: The Pipeline Report: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

    19 July 2017 | Treatment Action Group
  • WHO issues ethics guidance to protect rights of TB patients

    New tuberculosis (TB) ethics guidance, launched today by the World Health Organization (WHO), aims to help ensure that countries implementing the End TB Strategy adhere to sound ethical standards to protect the rights of all those affected.

    23 March 2017 | World Health Organization
  • Health alert: India has 25% of the world's tuberculosis patients

    Rising rates of superbug tuberculosis (TB) are threatening to derail decades of progress against the contagious disease, experts said on Thursday, and new drugs powerful enough to treat them are few and far between.

    23 March 2017 | Hindustan Times
  • TB Alliance partners with PepsiCo to advance the fight for improved medicines for children

    TB Alliance, a non-profit organization dedicated to developing better and faster cures for tuberculosis (TB), today announced a unique collaboration with food and beverage company PepsiCo designed to improve the treatment for children with TB. Many of today’s TB treatments are very bitter or unpleasant in taste, which when compounded with the long duration of treatment for TB, can lead to low tolerance and poor compliance – especially among children.

    28 October 2016 | TB Alliance
  • 47th Union World Conference on Lung Health: Even “free” TB treatment can come with catastrophic costs

    Even before the costs of getting diagnosed, picked up in some high-tuberculosis incidence countries by patients themselves, and even before treatment brings its own costs, the financial toll of tuberculosis has already begun, a representative of the World Health Organization said today.

    26 October 2016 | Science Speaks
  • TB drugs may be disrupted by botanical supplement, MU researchers find

    MU researchers, working with scientists in Africa, discovered that a widely used African botanical supplement called Sutherlandia — traditionally taken to prevent or treat symptoms of infections — may actually disrupt the effectiveness of a common anti-tuberculosis drug, isoniazid.

    11 October 2016 | Kansas City Star
  • Kenya to roll out child-friendly tuberculosis medicines nationwide

    TB medicines specially adapted for children have been available since 2015, as a result of the UNITAID-funded STEP-TB project. In 2013 UNITAID committed 16.72 million dollars towards the implementation of the STEP-TB project, which brought together TB Alliance, and other partners to develop the first formulations of TB medicines that meets dosage guidelines set by the World Health Organization (WHO) in 2010.

    27 September 2016 | UNITAID
  • WHO launches Target Regimen Profiles for TB treatment

    Aimed at the pharmaceutical industry, research institutions, product development partnerships and donors, the new profiles seek to guide the drug/regimen development process, enabling important drug and regimen features to respond to the needs of end-users, care providers and policymakers.

    08 September 2016 | World Health Organization
  • TB Can Persist in Lungs Despite Treatment

    The findings show that TB bacteria may persist in the lungs even after patients have finished treatment and are free of clinical symptoms. Although it is unclear how this might affect the risk of disease relapse, the study results underscore the need for new diagnostic methods and improved TB treatment strategies, according to the researchers.

    07 September 2016 | National Institute of Allergy and Infectious Diseases
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.